PRENYLATED CANNABINOIDS AND THEIR DERIVATIVES FOR THE TREATMENT OF CANCER

Fecha de publicación: --
Fuente: WIPO "tomato"
A composition includes a prenylated cannabinoid in an amount effective to modulate cannabinoid receptor CB2 activity; and a pharmaceutically or nutraceutically acceptable carrier; wherein the prenylated cannabinoid has the following formula (I):




R at each occurrence is farnesyl or geranylgeranyl; R1 at each occurrence is hydrogen or —COOR3; R2 at each occurrence is —C3-C20 alkyl; and R3 at each occurrence is selected from hydrogen, —C1-C20 alkyl, and —C1-C20 haloalkyl.